Hemfosa Fastigheter´s Joint venture SöderportFastigheter AB makes divestments totaling MSEK 170

Hemfosa´s joint venture Söderport, which is own equally with AB Sagax, has divested the propery Kamelen 14 in Malmö. The property currently comprises 13,500 square meters of office and business premises. The property has been unoccupied since October 2015 when the Swedish Police Authority vacated the premises. Söderport has initiated the preparation of a new zoning plan allowing conversion into residential units. The zoning plan has now gained legal force

The selling price amounts to MSEK 170 and the buyer is Riksbyggen. The propertie will be relinquished in the second quarter of 2016.

For further information, please contact:

Jens Engwall, CEO, tel: +46 706 90 65 50, e-mail: jens.engwall@hemfosa.se

About Hemfosa Fastigheter

Hemfosa is a Swedish property company with a property portfolio focused on service properties in the Nordics. This generates stable revenue flows and a healthy yield. Hemfosa also aims to create value by actively participating in the transaction market. As of March 31, 2016, Hemfosa owned commercial properties with a total property value of approximately SEK 32.6 billion, including the Company’s share of the property value in joint ventures. The Company’s ordinary share is listed as of March 2014 and preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.

Tags:

About Us

Hemfosa is a Swedish property company focusing on community service properties in the Nordic region with its largest tenants being the Swedish state and municipalities. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. As per June 30, 2016, Hemfosa owned properties with a total property value of approximately SEK 33.2 billion, including the company’s share of the property value in joint ventures. Hemfosa’s common share has been listed since March 2014 and its preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.

Subscribe

Documents & Links